Evaluation of Treatment Discontinuation Due to Adverse Events, and the Effect of Cardiovascular Risk Factors or Type of Jak-Inhibitors: An International Collaboration of Registries of Rheumatoid Arthritis Patients (The

AuthID
P-00X-QYQ
22
Author(s)
Aymon, R
·
Mongin, D
·
Choquette, D
·
Codreanu, C
·
Iannone, F
·
[+2]·
Lukina, G
·
Nordstrom, D
·
Pavelka, K
·
Pombo-Suarez, M
·
Rotar, Z
·
Santos, MJ
·
Courvoisier, D
·
Finckh, A
Document Type
Abstract
Year published
2022
Published
in ARTHRITIS & RHEUMATOLOGY, ISSN: 2326-5191
Volume: 74, Pages: 558-561 (4)
Indexing
Publication Identifiers
Wos: WOS:000877386500290
Source Identifiers
ISSN: 2326-5191
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Lauper, K;   2 Aymon, R;   3 Mongin, D;
4 Bergstra, SA;   5 Choquette, D;   6 Codreanu, C;
7 Elkayam, O;   8 Hyrich, K;   9 Iannone, F;
10 Inanc, N;   11 Kearsley-Fleet, L;   12 Kvien, TK;
13 Kristianslund, E;   14 Leeb, B;   15 Lukina, G;
16 Nordstrom, D;   17 Pavelka, K;   18 Pombo-Suarez, M;
19 Rotar, Z;   20 Santos, MJ;   21 Courvoisier, D;
22 Finckh, A;